Advertisement
Advertisement

ONCY

ONCY logo

Oncolytics Biotech, Inc.

0.7391
USD
-0.0319
-4.14%
Dec 18, 15:48 UTC -5
Closed
...

Oncolytics Biotech, Inc. Profile

About

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Info & Links

CEO

Matthew Coffey

Headquarters

804, 322 - 11 AVENUE SW
CALGARY, A0 T2R 0C5, CANADA

Industry

Biotechnology

Sector

Health Technology

Website

www.oncolyticsbiotech.com

Auditor

Ernst & Young LLP

Share holders

195

Employees

27

Oncolytics Biotech, Inc. Statistics

Valuation Measures

Market Capitalization2

56.96M

Enterprise Value

42.60M

Enterprise Value/EBITDA(ttm)

-1.66

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

9.45

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-141.15%

Return on Invested Capital(ttm)

-189.06%

Return on Assets(ttm)

-84.73%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-25.69M

Net Income Available to Common(ttm)

-20.28M

Diluted EPS(ttm)

-0.27

Share Statistics

Beta (5Y Monthly)

1.63

52-Week Change

-47.58%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

77.00M

% Held by Insiders

0.10%

% Held by Institutions

6.82%

Balance Sheet

Total Cash(mrq)

14.37M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.99%

Quick Ratio(mrq)

2.99%

Book Value Per Share(mrq)

0.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.18

Free Cash Flow(ytd)

-14.19M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement